A carregar...
Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada
IMPORTANCE: Cancer drugs approved by the US Food and Drug Administration have come under scrutiny for marginal clinical benefits; however, the clinical benefits of cancer drugs recommended for reimbursement in Canada have not been adequately studied. OBJECTIVE: To assess the differences in the clini...
Na minha lista:
| Publicado no: | JAMA Intern Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900938/ https://ncbi.nlm.nih.gov/pubmed/33616606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.8588 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|